Huifeng Bio-Pharmaceutical Technology raised $3.9 million in financing for a new Diosmin processing plant. Diosmin is a TCM nutritional supplement given to treat chronic venous insufficiency and hemorrhoids. The new facility will have the capacity to produce 500 tons of Diosmin each year, raising the company’s capacity to 600 tons, and generating up to $20 million in revenue annually. More details....

Stock Symbol: (OTCBB: HFGB)